Arvee Laboratories (India): The financial results for the period ended September 30, 2026

What happened

Arvee Laboratories (India) (ARVEE) filed a disclosure with the exchanges on 3 November 2026 at 06:59 PM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Arvee Laboratories (India) is a micro-cap company, with a market value of about ₹236 crore.

The stock last traded at ₹213.8, against a 52-week range of ₹129.1–₹290.8 (26.5% below the high).

Before this filing the shares had moved −6.7% over the month and +35.2% over three months. Average daily turnover over the last 20 sessions was about ₹0.16 crore.

Promoters held 73.50% at the end of Q1 FY27.

What history shows

BCEIE's records show 1 previous results filing from the company since May 2026.

Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 3 November 2026: Board meeting — Financial Results/Other business matters.

In the news

Recent coverage elsewhere (links open the original publisher):

• Arvee Laboratories (India) Limited (ARVEE.NS) Gains 3.88% to ₹177.9 as Buyers Reclaim Upper Range - Call Wall — https://www.siam.in/, 27 Oct 2026
• Arvee Laboratories (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent — MarketsMojo, 2 Nov 2026
• Arvee Laboratories (ARVEE.NS) Rallies 5% to ₹206.71, Nearing Resistance at ₹217.05 - Fibonacci Arc — https://www.siam.in/, 30 Oct 2026
• Arvee Laboratories (ARVEE.NS) Q2 2026 Earnings: EPS of ₹2.29 Holds Positive Even as Revenue Slips 18.21% YoY - Annual Financial Report — https://www.siam.in/, 30 Oct 2026

Source

• Exchange filing (PDF)